PT - JOURNAL ARTICLE AU - Nakagawa, Kuninori AU - Kanatani, Taro TI - Monday effect on confirmed cases of COVID-19 in Japan<sup>*</sup> AID - 10.1101/2021.07.20.21260858 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.20.21260858 4099 - http://medrxiv.org/content/early/2021/11/13/2021.07.20.21260858.short 4100 - http://medrxiv.org/content/early/2021/11/13/2021.07.20.21260858.full AB - We examined the phenomenon of fewer new confirmed cases of COVID-19 on Mondays in Japan, which we refer to as the Monday effect, and reveal the details of this effect. Specifically, we estimated the difference between the number of new positive cases that decreased over the weekend and the number of new confirmed cases that decreased at the beginning of the week. In Japan, prefectures aggregate and announce the number of confirmed daily cases. This analysis allows us to examine whether there is a Monday effect in each prefecture. We show that the Monday effect is due to the decreased number of inspections on the weekend appearing at the beginning of the week due to a time lag. Our results indicate that the administrative system causes delays in some prefectures, and that some prefectures are less likely to conduct screenings on holidays. Our results also suggest that delays generally occur in prefectures with a population of over 2 million. Congestion, Reporting delay, Public health, COVID-19Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We only use the daily data on the number of new positive cases by prefecture obtained from the public source, the NHK (Nippon Hoso Kyokai) website.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are obtained from public sources. https://www3.nhk.or.jp/news/special/coronavirus/